AEHR Aehr Test Systems, Inc.

Aehr Test Systems (AEHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

With global bond markets under pressure and the US 30-year Treasury yield at its highest level since 2004, cash has become more expensive and investors are rethinking where future growth could come from. That reset creates an opportunity to look at smaller AI-focused companies before they are widely discovered. This article discusses three small cap AI stocks from our screener that could be relevant for your watchlist. The three AI small caps highlighted below are just a starting sample, and...

Aehr Test Systems' 363% 2026 surge and 18.59X sales multiple reflect AI optimism, but customer concentration and execution risks leave little room for error.

One niche player burned cash and posted a net loss; the other generated $3.8 billion in free cash flow.

Aehr trades at a steep premium despite recent losses, while Super Micro's valuation looks cheap relative to its growth, but both carry hidden risks.

Aehr broadens beyond SiC as AI, silicon photonics and power semiconductors fuel a more diversified growth story.

Aehr Test Systems (AEHR) is positioned for an artificial intelligence-driven inflection as rising ch

Aehr's AI testing business gains momentum with major orders, new customer opportunities and a path toward recurring revenues.

Here is how Aehr Test Systems (AEHR) and Fortinet (FTNT) have performed compared to their sector so far this year.

Strong US jobs data and firm wage growth keep the focus on interest rates and the cost of capital. While large companies debate how fast to invest, smaller AI focused stocks can often move quicker and test new ideas in automation, data and machine learning. This article highlights three early stage AI small caps from our US screener that could help you think differently about long term growth. The stocks covered below are just a sample, and the full screen surfaced 26 more AI small caps with...

Aehr Test Systems (NASDAQ:AEHR) saw its share price climb by 13.10 percent on Friday as investors began positioning their portfolios ahead of business updates next week. According to the company, Chief Executive Officer Gayn Erickson and Chief Finance Officer Chris Siu are set to participate in meetings with institutional investors at the Lake Street Capital […]

William Blair Names 8 New Stock Picks: AI, Defense and Healthcare Stand Out

Aehr Test Systems stock has logged a very strong run over the past few years, yet the current valuation screens as expensive on broader checks. Recent pullbacks sit against a long multi year gain, which leaves investors weighing how much of the growth story is already reflected in the share price. Over the past 5 years, Aehr Test Systems has returned roughly 7 times an initial investment, which means expectations built into the stock are already very high. Future demand for its semiconductor...

Conference appearance gives investors a fresh window into Aehr Test Systems Aehr Test Systems (AEHR) is set to present at the Jefferies Semiconductor, IT Hardware & Communications Technology Conference on 25 August 2026. This appearance will give investors another look at management’s current priorities and messaging. That conference appearance comes after a sharp pullback in Aehr Test Systems’ recent share price, with the stock down 17.8% over the past week and 29.9% over the past three...

Rogers trimmed his direct holdings by 3% after the stock surged 695% over the past 12 months.

Aehr's record backlog, AI-driven orders and strong fiscal 2027 outlook give it an edge over Cohu despite a higher valuation.

Velo3D, Aehr Test Systems, and Atlassian have all rallied recently on improving revenue, bookings, and AI-driven demand, but each faces distinct risks to sustaining momentum.

Here is how Lam Research (LRCX) and Aehr Test Systems (AEHR) have performed compared to their sector so far this year.

Semiconductor test equipment stocks are getting hammered Wednesday while the broader chip ETF barely flinches, and the reason has nothing to do with bad earnings or analyst downgrades.

Aehr is betting on silicon photonics to drive sustained growth, as customer ramp ups and new orders are expected to support 15-20% of fiscal 2027 revenues.

The stock rallies were fueled by bullish analyst targets, stronger demand expectations and AI-driven growth catalysts.

Shares of semiconductor testing company FormFactor (NASDAQ:FORM) jumped 6.1% in the afternoon session after sentiment improved as peer, Aehr Test Systems, which provides similar semiconductor testing solutions announced it had received a $22 million follow-on production order from a major AI processor customer.

The insider disposed of 40,000 shares, representing a 10% reduction in total holdings.

A fresh Wall Street initiation just sent one of 2026's most explosive small caps through its all-time high, and the analyst behind it called the price target conservative while leaving several major catalysts completely out of the model.

AEHR's $22M AI order underscores rising WLBI demand as chip complexity and costs increase, while backlog and bookings point to strong growth.

Aehr Test Systems recently reported a strong fiscal fourth quarter with revenue of US$18.84 million, a return to profitability, and issued very bullish fiscal 2027 revenue guidance supported by record bookings and backlog. The company also disclosed a US$22 million follow-on production order from its lead wafer-level AI processor customer, highlighting growing adoption of its FOX-XP wafer-level burn-in platform for high-volume AI chip manufacturing in Taiwan. We’ll now examine how this large...

Aehr Test Systems (AEHR) is back in focus after a $22 million follow-on production order from its lead wafer-level AI processor customer, along with a recent fiscal Q4 update highlighting a return to profitability. See our latest analysis for Aehr Test Systems. The recent $22 million order and upbeat fiscal Q4 update have coincided with very strong share price momentum for Aehr Test Systems, including an 89.99% 1-month share price return and a very large 1-year total shareholder return. This...

AEHR shares rally on a $22 million follow-on production order. But caution is warranted in chasing the momentum in AEHR stock.

AEHR's 72.2% surge reflects record bookings, a $100.6M backlog and rising AI demand, but its premium valuation raises the stakes.

The insider's sale followed a 484% one-year total return for the stock.

Aehr Test Systems has surged over 400% this year on a dramatic business transformation, but with a price-to-sales ratio that would make most investors flinch and insiders quietly selling into the rally, the question now is whether the momentum has any room left to run.

The semiconductor test company reported another insider disposition amid its stock's 477% one-year return.

Here is how Flex (FLEX) and Aehr Test Systems (AEHR) have performed compared to their sector so far this year.

If you are looking for stocks that are well positioned to maintain their recent uptrend, Aehr Test Systems (AEHR) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Microsoft has posted eight straight quarters of revenue growth, while its smaller peer swung between sharp gains and declines.

The company reported a notable insider sale that reduced their indirect holdings by 21% as the stock surged 470% over the past year.

Both companies are burning cash and trading at steep multiples, but their paths to profitability, and their risks, couldn't be more different.

Aehr Test Systems (AEHR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Aehr Test Systems has delivered a very large 5 year return, yet the stock now screens as expensive on broad valuation checks despite the recent pullback. With the share price at US$76.87, the core issue is whether that long term gain now leaves little room for disappointment. Aehr Test Systems has returned about 12.6x over 5 years, which sets a very high bar for what investors may expect from here. Expectations for continued growth in its testing solutions can support the current valuation,...

The average of price targets set by Wall Street analysts indicates a potential upside of 49.6% in Aehr Test Systems (AEHR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Aehr's record bookings, AI-driven backlog and expanding burn-in portfolio give it the edge over FormFactor for long-term growth.

After losing some value lately, a hammer chart pattern has been formed for Aehr Test Systems (AEHR), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

The stock continues to trade as a proxy for AI semiconductor investment, and for good reason.

Aehr Test Systems soared by 27.86 percent on Tuesday to end at $98.91 apiece, as investors resorted to bargain-hunting after falling to the $75 level the previous day, while drawing encouragement from the flurry of AI expansion news that spilled over to industries riding the boom. Threefold Revenue Growth Outlook Despite Higher Losses Aehr Test […]

STT, AEHR and NBIS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 20, 2026.

Here is how Aehr Test Systems (AEHR) and Cisco Systems (CSCO) have performed compared to their sector so far this year.

KTTA, NTRS, YEXT, AEHR and STT have been added to the Zacks Rank #1 (Strong Buy) List on July 20, 2026.

Shares in Aehr Test Systems Inc. (NASDAQ:AEHR) jumped by 11.6 percent week-on-week, as investors increased their exposure after management posted a highly optimistic outlook for fiscal year 2027, thanks to the continued strong demand for semiconductor testing. In an updated report last week, the company said that it is targeting to grow its revenues during […]

Aehr Test Systems beat quarterly estimates and issued FY2027 revenue guidance of $130-$150 million, backed by a $100.6 million backlog and improved gross margins.

The company's burgeoning order growth is a good indicator of investment in AI processors.